New Clinical Data: Vagus Nerve Stimulation Stabilizes Cognitive Decline

Vagus Nerve Stimulation (VNS) is emerging as a potent bioelectronic intervention for Alzheimer’s disease. A pilot study involving 17 patients indicates that targeted electrical stimulation of the vagus nerve can effectively stabilize cognitive decline.

The mechanism operates via afferent pathways, enhancing cholinergic tone and suppressing neuroinflammation. This promotes neuroplasticity in neural circuits critical for memory retention and executive function.

Clinical data showed that 71% of participants remained stable or improved on the Mini-Mental State Examination (MMSE). Additionally, 41% showed no decline on the ADAS-cog scale over the one-year observation period.

Cerebrospinal fluid analysis revealed a reduction in total tau protein, a marker of axonal degeneration. Beta-amyloid and phospho-tau levels remained stable, suggesting a deceleration in structural decay.

Patients tolerated the implants well, experiencing only minor side effects like transient voice alterations. These findings suggest that modulating internal neural highways can shield the brain from progressive atrophy.

https://pubmed.ncbi.nlm.nih.gov/16541247/

https://www.nature.com/articles/s41582-019-0264-z

https://www.alz.org/alzheimers-dementia/research_progress/earlier-diagnosis/biomarkers

https://pubmed.ncbi.nlm.nih.gov/16965193

1 comment